Research

Backed by Clinical Evidence

Real world evidence from more than 4800 samples over 7 years found Delve Detect delivers 22% greater diagnostic yield than all other infectious disease tests combined.

Evidence Spotlight

Largest study on mNGS using CSF confirms its impact in diagnosing serious neurological infections

A groundbreaking study published in Nature Medicine, the largest of its kind, establishes mNGS as a crucial diagnostic tool for central nervous system (CNS) infections. Findings showed that mNGS technology significantly enhances diagnostic yield, supporting faster, targeted treatment decisions for patients.

research-mobile
research-img

Ebook

How metagenomic next generation sequencing is revolutionizing how we treat and manage infectious diseases

Metagenomic next-generation sequencing is rewriting what’s possible in pathogen detection, microbiome research, and beyond. This 5-chapter guide cuts through the noise: from sequencing fundamentals to real-world implementation, wet lab considerations to bioinformatics pipelines, and the strategic decisions that separate teams who get results from teams who get data.
Chapter 1 is yours immediately, free and ready to view.


Ready to go deeper?

Chapters 2–5 are available in full. 
Tell us a bit about yourself and we’ll send you the complete guide.

Want to hear more about our technology?